What is it about?
Human neuroendocrine tumours arise in different organs including most frequently in the gall bladder, kidneys, and ovaries or testicles. Liver neuroendocrine tumours are rarer types that grow slowly and arise from neuroendocrine cells.
Featured Image
Photo by Europeana on Unsplash
Why is it important?
The gastroduodenal endoscopic evaluation revealed severe gastritis with mild erythema in the corpus and antrum of the stomach with no evidence of esophagitis or duodenitis. At the time of initial diagnosis, the patient was asymptomatic for a liver neuroendocrine tumour as she did not have anemia, weight loss, abdominal distension, severe abdominal pain, or a palpable right upper quadrant mass.
Perspectives
Neuroendocrine tumours (NETs) have a prevalence rate of 1-2% among all gastrointestinal tract tumours. They are higher in the trachea bronchopulmonary system and pancreas [1]. A study that described NETs in 1958 [2] reported the liver as the most common site of metastatic spread for these tumours [3].
Acquire Publications
Read the Original
This page is a summary of: Successful Correction of the Misdiagnosis of a Primary Liver Neuroendocrine Tumour with a Combination of Immunohistochemical and Radiological Assessments: Report of a Rare Case from Pakistan, Journal of Case Reports and Medical History, March 2024, Acquire Publications LLC,
DOI: 10.54289/jcrmh2400123.
You can read the full text:
Contributors
The following have contributed to this page
